The deaths of two men in Coronavirus are not likely to be linked to their recent coronavirus vaccination. Australia.
According to the head of the Australian Medicines Regulatory Authority, there is no evidence linking the deaths of two Australians to vaccine doses. COVID-19 they had received.
The deaths, which were recorded in the most populous state of New South Wales, occurred a few days after the two men were vaccinated, as reported by AMPE, citing media.
One was 71 years old with underlying diseases and had done it AstraZeneca vaccine, according to Seven News. The other, 55 years old, died within eight days from the day he had the vaccine, writes referring to his family, a newspaper in the northwestern city of Tamworth.
However the data do not appear to be related to their COVID-19 vaccination, said John Scherit, head of the Australian drug agency TGA.
“The current data do not suggest a possible connection,” Scherit told reporters in Canberra. “We have to remember that unfortunately every week in Australia 3,000 people die from all kinds of causes,” he said.
With just over 29,700 cases of the new coronavirus and 910 deaths from COVID-19 since the outbreak of the pandemic, Australia has largely avoided high rates of infection in other developed countries, but its population vaccination campaign has faced various obstacles.
It uses AstraZeneca and Pfizer vaccines. However, authorities abandoned their goal of reaching the population of nearly 26 million people by the end of 2021 this month, after identifying a possible link between the AstraZeneca vaccine and rare blood clots.
Australia has reduced the availability of the AstraZeneca vaccine in people over the age of 50, which disrupted the vaccination campaign, as it relied on this vaccine for the majority of vaccinations.
More than 2 million doses of COVID-1 vaccine had been given in Australia as of Tuesday, far short of the 4 million expected to be given in the country by the end of March.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
